X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

PTCT

Closed

Ptc Therapeutics Inc

48.59
-0.25 (-0.51%)
Last Update: 01 Jul 2025 23:26:00
Yesterday: 48.84
Day's Range: 48.2 - 50.04
Send
When Written:
 
48.63
PTC Therapeutics Inc. is a biopharmaceutical company that focuses on the discovery and development of novel small molecule drugs for the treatment of rare and genetic disorders. The company was founded in 1998 and is headquartered in South Plainfield, New Jersey, USA.

PTC Therapeutics is best known for its drug Translarna (ataluren), which is used to treat Duchenne muscular dystrophy (DMD) caused by a nonsense mutation. The company also has several other drugs in its pipeline, including PTC923, PTC299, and PTC596, which are being developed for the treatment of various genetic disorders.

PTC Therapeutics has partnerships with several pharmaceutical companies, including Roche, Novartis, and Genzyme, to develop and commercialize its drugs. The company has also received funding from various sources, including the National Institutes of Health (NIH) and the Muscular Dystrophy Association (MDA).

Overall, PTC Therapeutics is a leading player in the field of rare and genetic disorders, with a focus on developing innovative treatments for patients with unmet medical needs.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X